Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 9,814 | 8,930 | 10,941 | 10,623 | 8,767 |
| Operating Income | -9,814 | -8,930 | -10,941 | -10,623 | -8,767 |
| Other Income | 611 | 671 | 582 | 378 | 244 |
| Pre-tax Income | -9,203 | -8,259 | -10,359 | -10,244 | -8,524 |
| Net Income Continuous | -9,203 | -8,259 | -10,359 | -10,244 | -8,524 |
| Net Income | $-9,203 | $-8,259 | $-10,359 | $-10,244 | $-8,524 |
| EPS Basic Total Ops | -14.00 | -13.00 | -17.00 | -20.00 | -16.00 |
| EPS Basic Continuous Ops | -14.30 | -12.85 | -17.17 | -19.30 | -16.26 |
| EPS Diluted Total Ops | -14.00 | -13.00 | -17.00 | -20.00 | -16.00 |
| EPS Diluted Continuous Ops | -14.30 | -12.85 | -17.17 | -19.30 | -16.26 |
| EBITDA(a) | $-9,771 | $-8,887 | $-10,897 | $-10,577 | $-8,720 |